Atlas of clinical PET-CT in treatment response evaluation in oncology / Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrió, editors.
Fanti, Stefano, editor.; Gnanasegaran, Gopinath, editor.; Carrió, Ignasi, editor.
2021
RC270.3.T65
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Atlas of clinical PET-CT in treatment response evaluation in oncology / Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrió, editors.
ISBN
9783030688585 (electronic bk.)
3030688585 (electronic bk.)
9783030688578 (print)
3030688577 (print)
DOI
https://doi.org/10.1007/978-3-030-68858-5
Published
Cham : Springer, [2021]
Language
English
Description
1 online resource (xiii, 488 pages) : illustrations
Item Number
10.1007/978-3-030-68858-5 doi
Call Number
RC270.3.T65
Dewey Decimal Classification
616.99/40757
Summary
"This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods."--Publisher's description
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file
PDF
Source of Description
Resource, viewed October 4, 2021.
Added Author
Fanti, Stefano, editor.
Gnanasegaran, Gopinath, editor.
Carrió, Ignasi, editor.
Available in Other Form
Print version: 9783030688578
Print version: 9783030688578
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Part I. Therapy response evaluation: science and practice. Treatment response evaluation: science and practice
CT in treatment response assessment in oncology
MRI and Diffusion-Weighted MRI in Treatment Response Evaluation Overview
PET and PET-CT in treatment response evaluation: overview
Conventional radiological techniques and PET-CT in treatment response evaluation in postsurgical setting
Conventional radiological and PET-CT assessment of treatment response evaluation in chemotherapy setting
Conventional radiological techniques and PET-CT in treatment response evaluation in post-radiotherapy setting
Conventional radiological techniques and PET-CT in treatment response evaluation in immunotherapy settings
Treatment response evaluation of bone metastases using 18F-NaF
Reporting post-therapy scans
Part II. Therapy response evaluation: clinical atlas. 18F-FDG PET/CT in treatment response evaluation in head and neck cancer
PET/CT in treatment response evaluation: lung cancer
18F-FDG PET/CT and Non 18 F-FDG-PET/CT in treatment response evaluation in neuro-oncology
PET/CT in the assessment of treatment response in hepatobiliary, gall bladder and pancreatic malignancies
18F-FDG PET/CT in treatment response evaluation: gastroesophageal cancer
PET-CT in treatment response evaluation in lymphoma
18F-FDG PET/CT in treatment response evaluation: breast cancer
18F-Choline, 68Ga-PSMA-11 and 18F-FDG PET/CT in treatment response evaluation: prostate cancer
FDG PET/CT in treatment response evaluation of gynecological malignancies
[18 F]FDG PET/CT in treatment response evaluation: colorectal cancer
18F-FDG PET in treatment response evaluation: soft tissue sarcomas
18F-FDG PET-CT in treatment response evaluation in cutaneous malignant melanoma
18F-FDG PET-CT in treatment response evaluation: multiple myeloma
18F-FDG PET-CT and 18 F-NaF in treatment response evaluation: bone metastases and bone tumours
FDG-PET/CT in assessment of treatment response in pediatric lymphoma
18 F-FDG PET/CT in treatment response evaluation in thyroid cancer
68Ga-DOTA PET-CT in treatment response evaluation: neuroendocrine tumours
18F-FDOPA PET/CT for treatment response assessment
18F-FLT/FET PET-CT in treatment response evaluation.

Browse Subjects

Show more subjects...

Statistics

from
to
Export